original ) (raw )Heart failure biomarkers in patients with dilated cardiomyopathy
Maciej Banach
International journal of cardiology, 2013
View PDFchevron_right
Influence Of Different Aetiologies On Clinical Course And Outcome In Patients With Dilated Cardiomyopathy
Claus Lüers
European Journal of Clinical Investigation, 2015
View PDFchevron_right
Clinical and Prognostic Value of Duke's Activity Status Index Along With Plasma B-Type Natriuretic Peptide Levels in Chronic Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
Sousanna-Maria Nikolaou
The American Journal of Cardiology, 2009
View PDFchevron_right
The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
Manuel Campelo
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2017
View PDFchevron_right
Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
Mirta Kozelj
ESC Heart Failure, 2020
View PDFchevron_right
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure – a subgroup analysis from the Trieste Cardiomyopathy Registry
Stylianos Pyxaras
View PDFchevron_right
Electrocardiographic markers of impaired left ventricular function in idiopathic dilative cardiomyopathy (DCM)
Ulrich Eberlein
Journal of Electrocardiology, 1990
View PDFchevron_right
Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study
Antonello Gavazzi
International Journal of Cardiology, 2013
View PDFchevron_right
Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure
Manuel Portolés
Journal of cardiac …, 2007
View PDFchevron_right
Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy
G. Dec
Journal of the American College of Cardiology, 2011
View PDFchevron_right
Coronary Flow Reserve in Idiopathic Dilated Cardiomyopathy: Relation with Left Ventricular Wall Stress, Natriuretic Peptides, and Endothelial Dysfunction
Stefano Taddei
Journal of the American Society of Echocardiography, 2009
View PDFchevron_right
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
Andrew Coats
European Journal of Heart Failure, 2021
View PDFchevron_right
Risk Stratification in Chronic Heart Failure: Independent and Incremental Prognostic Value of Echocardiography and Brain Natriuretic Peptide and its N-terminal Fragment
Thomas Wichter
Journal of the American Society of Echocardiography, 2006
View PDFchevron_right
Serum Pro‐N‐Cadherin Is a Marker of Subclinical Heart Failure in the General Population
Ishaan Puranam
Journal of the American Heart Association, 2023
View PDFchevron_right
Serum Uric Acid Levels Correlate With Left Atrial Function and Systolic Right Ventricular Function in Patients With Newly Diagnosed Heart Failure: The Hellenic Heart Failure Study
Stella Brili
Congestive Heart Failure, 2008
View PDFchevron_right
A Propensity-Matched Study of the Association of Cardiothoracic Ratio With Morbidity and Mortality in Chronic Heart Failure††The Digitalis Investigation Group (DIG) study was conducted and supported by the NHLBI in collaboration with the DIG investigators. This report was prepared using a limited...
Thomas Love
The American Journal of Cardiology, 2008
View PDFchevron_right
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology: reply
Frank Rademakers
European Heart Journal, 2007
View PDFchevron_right
Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy
David Vancraeynest
JACC: Cardiovascular Imaging, 2015
View PDFchevron_right
Identification of High-Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function
Luisa Zanolla
Clinical Cardiology, 2012
View PDFchevron_right
Independent Value of Echocardiography and N-Terminal Pro-Natriuretic Peptide for the Prediction of Major Outcomes in Patients With Suspected Heart Failure
Sajad Hayat
The American Journal of Cardiology, 2007
View PDFchevron_right
An Etiological Study of Dilated Cardiomyopathy in Correlation with Clinical, ECG And Echocardiographic Profile
Divakar Kumar
IOSR Journal of Dental and Medical Sciences, 2017
View PDFchevron_right
Diastolic heart failure in the community: Clinical profile, natural history, therapy, and impact of proposed diagnostic criteria
Michele Senni
Journal of Cardiac Failure, 2002
View PDFchevron_right
Comparative Analysis of Clinical Profile of Patients Admitted with Idiopathic Dilated Cardiomyopathy in a Tertiary Care Hospital
Bambang B Siswanto
Journal of Cardiovascular Disease Research, 2017
View PDFchevron_right
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction
Michele Emdin
Peptides, 2007
View PDFchevron_right
The long-term outcome of patients with hypertensive cardiomyopathy
Mariana Cúri
Journal of Human Hypertension, 2005
View PDFchevron_right
The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure
emrah ipek
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2014
View PDFchevron_right
Uric Acid and Survival in Chronic Heart Failure Validation and Application in Metabolic, Functional, and Hemodynamic Staging
rakesh sharma
View PDFchevron_right